1. The Complainant has established the fact that it has valid trademark rights for BIODERMA in class 3. The disputed domain name is confusingly similar to the trademark of the Complainant since the part “scincare” of the disputed domain name is descriptive and does not significantly contribute to the distinctiveness of the mark.
The Panel therefore considers the disputed domain name to be confusingly similar to the BIODERMA trademarks in which the Complainant has rights in accordance with paragraph 4(a)(i) of the Policy.
2. The Respondent has no rights or legitimate interests in the disputed domain name as the Respondent is not a licensee of the Complainant nor has the Complainant granted the Respondent any permission or given its consent to use its trademarks. Furthermore, the Respondent has no rights or legitimate interests in the disputed domain name as there is no indication that the Respondent is commonly known by the name “BIODERMA” or that the Respondent is using the disputed domain name in connection with a bona fide offering of goods or services.
The Panel therefore finds that the Respondent does not have rights or legitimate interests in the disputed domain name.
3. In the view of the Panel, the Respondent must have been aware of the widely known Complainant and its trademarks when registering the disputed domain name. The Complainant has not authorized the Respondent to make use of its trademarks. From the record, the Panel does not see any conceivable legitimate use being made by the Respondent of the disputed domain name.
The circumstances of this case, in particular the website showing competitive products indicate that the Respondent registered and uses the disputed domain name primarily with the intention of attempting to attract, for commercial gain, Internet users to its potential website or other online locations, by creating a likelihood of confusion with the Complainant’s mark as to the source, sponsorship, affiliation, or endorsement of such website or location, or of a product or service on such website or location. The Panel therefore considers the disputed domain name to have been registered and used in bad faith in accordance with paragraph 4(a)(iii) of the Policy.
|